Mid-Term Outcomes of a Next-Generation Modular Acetabular System in Primary and Revision Total Hip Arthroplasty
Journal of Clinical Medicine · 31.05.2026 · 15 (11) · 4258
DOI: 10.3390/jcm15114258 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 31.05.2026. Verfasst von Garrett Ruff und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, NYU Langone Health, New York, NY 10016, USA. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zimmer Biomet.
Abstract (Originalsprache)
Background/Objectives: Total hip arthroplasty (THA) is a common orthopedic procedure, and with projected growth in both primary and revision surgical volumes, robust implant performance data is necessary to inform surgical decision-making. To ensure successful outcomes in primary THA (pTHA) and revision THA (rTHA), surgeons need versatile implant systems that can address patient-specific surgical challenges. This study aimed to evaluate the outcomes of a next-generation acetabular system used for various indications in both pTHA and rTHA.
Methods
We retrospectively reviewed 319 patients who underwent either pTHA or rTHA using a modern acetabular system at a single urban academic center between 2014 and 2023 with at least 18 months of follow-up. Baseline characteristics and the patient-reported Hip Disability and Osteoarthritis Outcome Score, Joint Replacement (HOOS, JR) were collected. A total of 284 patients who underwent pTHA and 35 patients who underwent rTHA were included. Median follow-up was 2.6 years (range: 1.5–8.4 years).
Results
The most common indication was osteoarthritis (90%) for pTHA and instability (46%) for rTHA. Most rTHAs utilized a dual-mobility construct (74%), compared to pTHAs (22%). There were ten all-cause acetabular revisions in the entire cohort (eight in pTHA, two in rTHA), four of which were aseptic (three in pTHA, one in rTHA). All-cause and aseptic acetabular survivorship of the pTHA cohort was 97.2% and 98.7%, respectively, and of the rTHA cohort was 94.3% and 97.1%, respectively. Improvement in the median HOOS, JR score was 21.5 points at one year and 25.5 points at two years among pTHAs.
Conclusions
The findings with this system support adequate mid-term acetabular component survivorship in pTHA and rTHA, along with clinically meaningful functional improvement following pTHA. Given the retrospective, observational nature of this study, further prospective research with extended follow-up and larger sample sizes, particularly in the rTHA cohort, is needed to better assess long-term outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, NYU Langone Health, New York, NY 10016, USA.
- The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3525433, Israel.
ORCID-Profile: Garrett Ruff, Laith Bahlouli, Anzar Sarfraz, Farouk Khury, Vinay K Aggarwal
Förderung
- Zimmer Biomet
Zitieren
APA
Ruff, G., Bahlouli, L., Sarfraz, A., Khury, F., Arsoy, D., Lajam, C., & Aggarwal, V. K. (2026). Mid-Term Outcomes of a Next-Generation Modular Acetabular System in Primary and Revision Total Hip Arthroplasty. Journal of Clinical Medicine, 15(11), 4258. https://doi.org/10.3390/jcm15114258
Vancouver
Ruff G, Bahlouli L, Sarfraz A, Khury F, Arsoy D, Lajam C, et al. Mid-Term Outcomes of a Next-Generation Modular Acetabular System in Primary and Revision Total Hip Arthroplasty. Journal of Clinical Medicine. 2026;15(11):4258. doi:10.3390/jcm15114258
BibTeX
@article{Ruff2026,
author = {Ruff, Garrett and Bahlouli, Laith and Sarfraz, Anzar and Khury, Farouk and Arsoy, Diren and Lajam, Claudette and Aggarwal, Vinay K},
title = {Mid-Term Outcomes of a Next-Generation Modular Acetabular System in Primary and Revision Total Hip Arthroplasty},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {11},
pages = {4258},
doi = {10.3390/jcm15114258}
}
EUVIMED